Mauna Kea Technologies SA (LON:0P5I)

Market Cap	9.96M -5.0%
Revenue (ttm)	7.01M +0.3%
Net Income	-8.90M
EPS	-0.12
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38,263
Average Volume	20,765
Open	0.1270
Previous Close	0.1210
Day's Range	0.1182 - 0.1270
52-Week Range	0.0694 - 0.1920
Beta	1.28
RSI	55.50
Earnings Date	Apr 9, 2026

About Mauna Kea Technologies

Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate reactions as they occur, classify areas of uncertainty, guide surgical interventions, and help diagnose and treat patients. The company was incorporat...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2000
• Employees: 61
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0P5I

Financial Performance

In 2024, Mauna Kea Technologies's revenue was 8.42 million, a decrease of -23.69% compared to the previous year's 11.03 million. Losses were -10.40 million, 179.2% more than in 2023.

Financial numbers in EUR